VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Operating cash flow, 2025
- $3.6B
- 5-year CAGR
- +2.2%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $3.6B | — |
| 2024 | −$493M | — |
| 2023 | $3.5B | −14.3% |
| 2022 | $4.1B | +56.2% |
| 2021 | $2.6B | −18.7% |
| 2020 | $3.3B | +107.3% |
| 2019 | $1.6B | +23.5% |
| 2018 | $1.3B | +50.3% |
| 2017 | $845M | +257.9% |
| 2016 | $236M | — |
| 2015 | −$365M | — |
| 2014 | −$573M | — |
| 2013 | −$61M | — |
| 2012 | $268M | +86.3% |
| 2011 | $144M | — |
| 2010 | −$635M | — |
| 2009 | −$428M | — |
| 2008 | −$226M | — |